Multiple Sclerosis
Telehealth clinic reduces distress among people with graft-versus-host disease
A multidisciplinary, virtual platform showed preliminary feasibility for reducing distress and improving access for patients with graft-versus-host disease, according to findings published in Transplantation and Cellular Therapy.
Large language model may improve diagnosis of multiple sclerosis
WEST PALM BEACH, Fla. — Large language model algorithms may be reliable for synthesizing large patient databases to more rapidly and accurately diagnose multiple sclerosis, according to a poster presented at ACTRIMS.
Fampridine may have positive impact for optic neuritis in multiple sclerosis
WEST PALM BEACH, Fla. — Treatment with fampridine may positively impact patients with multiple sclerosis who are recovering from optic neuritis, but more extensive clinical trials are required to fully assess its effectiveness, according to a poster at ACTRIMS.
Women oncologists receive significantly lower general payments from industry than men
An analysis of industry payments to medical oncologists showed men received significantly higher speaker fees, consulting fees and other general payments than women between 2016 and 2020.
AI helps identify psychiatric comorbidities in multiple sclerosis
WEST PALM BEACH, Fla. — A machine learning model using existing clinical data may help clinicians screen for comorbid anxiety and depression in patients with multiple sclerosis, according to a poster presented at ACTRIMS.
Real-world ublituximab for MS demonstrates similar clinical benefits as in phase 3 studies
WEST PALM BEACH, Fla. — Real-world effects of ublituximab after 1 year of administration were consistent with data from a pair of phase 3 clinical trials investigating the drug, according to a poster presented at ACTRIMS.
ADHD linked to earlier age at MS diagnosis
WEST PALM BEACH, Fla. — Researchers have identified a positive association between multiple sclerosis and ADHD, as well as a trend toward an earlier diagnosis of MS among those with ADHD, according to a poster presented at ACTRIMS.
Risks of ending disease-modifying therapy may be ‘minimal’ in older, stable adults with MS
WEST PALM BEACH, Fla. — It may be sensible for older patients with MS who have prolonged stability to cease disease-modifying therapy, but more data are needed to understand the effects of discontinuation in this group, an expert said.
Physical activity lowers risk for disability worsening in multiple sclerosis
WEST PALM BEACH, Fla. — For patients with MS, the risk for disability worsening was reduced with physical activity, highlighting the importance of recommending it in practice, researchers reported at ACTRIMS.
Comorbidities linked to early discontinuation of disease-modifying therapy trials for MS
WEST PALM BEACH, Fla. — A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients with MS who participated in phase 3 clinical trials of disease-modifying therapies, data show.